OPTION TO PURCHASE SENIOR CONVERTIBLE NOTEOption to Purchase Senior Convertible Note • January 11th, 2019 • Innovate Biopharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 11th, 2019 Company Industry JurisdictionThis option is granted and effective as of January 7, 2019 (the “Effective Date”) by and between Gustavia Capital Partners LLC and/or its affiliates, the holders of the Senior Convertible Note originally issued to Gustavia Capital Partners LLC (collectively, “Holder”) and Innovate Biopharmaceuticals, Inc., a Delaware corporation (“INNT” or the “Company”).